In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
On December 26, 2017, Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leading comp···【more】
Release date:2025-12-31Recommended:338
The approval of ivosidenib for its indicated uses by the U.S. Food and Drug Admi···【more】
Release date:2025-12-31Recommended:306
The dosage of Ivosidenib may vary among different patients.What is the recommend···【more】
Release date:2025-12-31Recommended:302
Ivosidenib is also indicated for the treatment of previously treated cholangioca···【more】
Release date:2025-12-31Recommended:319
Ivosidenib is the first approved drug of the IDH1 inhibitor class. It works by i···【more】
Release date:2025-12-31Recommended:304
Ivosidenib targets a specific gene mutation called IDH1, which may affect your b···【more】
Release date:2025-12-31Recommended:313
Ivosidenib can be used for the treatment of relapsed or refractory acute myeloid···【more】
Release date:2025-12-31Recommended:430
Ivosidenib, either as a monotherapy or in combination with azacitidine, is indic···【more】
Release date:2025-12-31Recommended:354
Tibsovo® (ivosidenib tablets) is the first tumor metabolism-targeted therapy app···【more】
Release date:2025-12-31Recommended:342
On October 24, 2023, Servier, a leader in the oncology field dedicated to bringi···【more】
Release date:2025-12-31Recommended:374
LuciusVersionofIbrutinib:DosageandAdministration,Indications,PrecautionsIndicati···【more】
Release date:2025-12-18Recommended:337
LuciusVersionofDeucravacitinib:DosageandAdministration,Indications,PrecautionsIn···【more】
Release date:2025-12-18Recommended:325